CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34(+) hemopoietic progenitors cells.
about
Cancer stem cells in basic science and in translational oncology: can we translate into clinical application?The SIRT1/TP53 axis is activated upon B-cell receptor triggering via miR-132 up-regulation in chronic lymphocytic leukemia cells.NOTCH1 Is Aberrantly Activated in Chronic Lymphocytic Leukemia Hematopoietic Stem Cells.
P2860
CD49d expression identifies a chronic-lymphocytic leukemia subset with high levels of mobilized circulating CD34(+) hemopoietic progenitors cells.
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh-hant
name
CD49d expression identifies a ...... of mobilized circulating CD34
@nl
CD49d expression identifies a ...... hemopoietic progenitors cells.
@en
type
label
CD49d expression identifies a ...... of mobilized circulating CD34
@nl
CD49d expression identifies a ...... hemopoietic progenitors cells.
@en
prefLabel
CD49d expression identifies a ...... of mobilized circulating CD34
@nl
CD49d expression identifies a ...... hemopoietic progenitors cells.
@en
P2093
P2860
P50
P356
P1433
P1476
CD49d expression identifies a ...... hemopoietic progenitors cells
@en
P2093
P2860
P2888
P304
P356
10.1038/LEU.2013.331
P50
P577
2013-11-08T00:00:00Z